what we prescribe

• Paxlovid consists of nirmatrelvir, which inhibits a SARS-CoV-2 protein to stop the virus from replicating, and ritonavir, which slows down nirmatrelvir’s breakdown to help it remain in the body for a longer period at higher concentrations.
• Indicated for patients with positive results of direct SARS-CoV-2 testing.
• Recommend for symptomatic patients who have mild to moderate COVID-19 and risk factors for progression to severe disease.

Contraindication

Paxlovid is not authorized in the following setting:

• Prevention of COVID-19.
• Patient under 50 yrs with no risk factors or underlying medical conditions.
• In those requiring hospitalization due to severe COVID-19.
• Paxlovid is not a substitute for vaccination.
• Individuals who have SARS-CoV-2 infection but do NOT have symptioms.
• Individuals without any risk factors for progression to severe disease.

Warning

• Possible side effects of Paxlovid include impaired sense of taste, diarrhea, high blood pressure and muscle aches.
• May result in potentially significant drug interactions if used at the same time as certain other drugs.
• May lead to HIV-1 drug resistance in people with uncontrolled or undiagnosed HIV-1 infection.
• Paxlovid is not recommended in patients with severe kidney and liver impairment.

Paxlovid Requirements

NOTE: Paxlovid can only be prescribed if you meet ALL of the following requirements:

• Age 30+.
• Positive for COVID-19.
• If you have underlying medical conditions such as hypertension, diabetes, heart condition, lung disease.